COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.
Description:
Chronic obstructive pulmonary disease or COPD is a progressive disease that makes it hard to breathe. Progressive means the disease gets worse over time. It is a group of diseases which include chronic bronchitis and emphysema, which can result in COPD. A COPD diagnosis means the patient may have one of these lung damaging disease or symptoms COPD can progress gradually, making it increasingly difficult to breathe over time.
COPD happens when the lungs and the airways become damaged and inflamed caused by various factors. It’s usually associated with the long term exposure to harmful substances such as cigarette smoke and exposure to an unhealthy environment. Smoking is the main cause of COPD and is thought to be responsible for around 9 in every 10 cases. The harmful chemicals in smoke can damage the lining of the lungs and airways. Exposure to certain types of dust and chemicals at work may damage the lungs and increase your risk of COPD. COPD makes breathing increasingly more difficult, but it develops slowly over many years and people may not be aware when they have it at first. Most people with COPD do not have any noticeable symptoms until they reach their late 40s and 50s.
Common symptoms of COPD include increasing breathlessness (this may only happen when exercising at first and people may sometimes wake up at night feeling breathless), a persistent chesty cough with phlegm that does not go away, frequent chest infections, and persistent wheezing. The symptoms will usually get gradually worse over time and make daily activities increasingly difficult, although treatment can help slow down the progression. Currently, there is no cure for COPD, but treatment can help slow the progression of the condition and control the symptoms. Several kinds of medications are used to treat the symptoms and complications of COPD. Bronchodilators are the medications that usually come in inhalers. They relax the muscles around airways, which can help relieve coughing and shortness of breath and make breathing easier. Another medication used for people with severe COPD is roflumilast, a phosphodiesterase 4 inhibitor. Inhaled steroids can also be used to treat COPD, as these are helpful for people with frequent exacerbation of COPD.
Increasing smoking habits among people across the globe has increased the cases of COPD, which, in turn, is boosting the market growth. Genetic disorders caused by alpha 1 antitrypsin deficiency is also another driving factor for the COPD treatment market. Rising air pollution across the globe is yet another factor that is increasing the cases of COPD. However, side effects of drugs used for the treatment of COPD may act as a restraint to market growth.
Some impact factors:
What does this Report Provide?
This report provides a detailed understanding of the global Chronic obstructive pulmonary disease treatment demand from a qualitative and quantitative perspective with a forecast for the next 10 years. The report also provides dynamic indicators with potential impact in the market during the forecast period and an in-depth analysis of the leading companies operating in the global Chronic obstructive pulmonary disease treatment market. The major market drivers, challenges, and opportunities for the global Chronic obstructive pulmonary disease treatment market are also covered in the report. This report also includes the market share of the leading Chronic obstructive pulmonary disease treatment producers along with their production capacities and growth strategies adopted by them.
Market Segmentation:
By Drug Class:
By Route of Administration:
By Distribution Channel:
By Region:
North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Major Companies: In this report we have studied the following major companies - AstraZeneca Plc, Orion Corporation, Mylan N.V., Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Novartis AG, Sunovion Pharmaceuticals, Inc., and CHIESI Farmaceutici SpA.
Objectives of this report:
Customization:
This study is customized to meet your specific requirements:
For more information, contact: [email protected]
Single User (PDF)
3850Multi User (PDF)
5150Enterprise User (PDF)
7650Avail customized purchase options to meet your exact research needs.
Detailed scope covering all the major segments in the market
In line data validations to ensure data precision
Market recommendations supporting decision making processes
Round the clock analyst support to resolve your queries
Up to 15% additional free customization to meet your specific requirements